BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2009
View Archived Issues
New data demonstrate potential of GLP-1 analogues for neurodegenerative diseases
Read More
Baminercept is safe but has no apparent efficacy in phase Ib trials in RA
Read More
LX-2931 is safe in combination with methotrexate in patients with stable RA
Read More
Antisense oligonucleotides targeting huntingtin show promise for the treatment of HD
Read More
Amura describes cathepsin S inhibitors for the treatment of RA
Read More
Tubulin polymerization inhibitors for cancer therapy presented by U.S. scientists
Read More
Novel MEK inhibitor G-573 tested in tumor xenograft models
Read More
AMT and Progenika to develop LPLchip to diagnose lipoprotein lipase deficiency
Read More
BioPorto reports technical data of NGAL diagnostic test for acute kidney injury
Read More
BioMerieux launches MRSA screening tool
Read More
Thermo Fisher Scientific launches new biomarker test for heart attack
Read More
Morphotek enters into licensing agreement with Centocor for anticancer therapeutic antibody
Read More
Sunesis completes enrollment in voreloxin trial in acute myeloid leukemia
Read More
AcelRx completes end-of-phase II meeting for ARX-01 analgesic
Read More
UCB reports results from third quarter of 2009
Read More
Shire reports tolerability and clinical effects of Daytrana in adolescents with ADHD
Read More
HGS and GSK report results for second of two phase III Benlysta trials in SLE
Read More
Lundbeck starts clinical phase IIa trial of Lu-AA24493 in Friedreich's ataxia
Read More
Byetta approved for expanded use as first-line treatment for type 2 diabetes
Read More
FDA issues complete response letter regarding Schering-Plough's sBLA for Pegintron
Read More
Solasia completes phase I trial of Sancuso for chemotherapy-induced nausea
Read More
Geron and FDA agree on conditions to lift clinical hold on phase I trial of GRNOPC1
Read More
ATLAS I and II data show efficacy of telavancin in cellulitis and infected ulcers
Read More
Novel hybrid peptide vaccine is safe and immunogenic in phase I trial in prostate cancer
Read More
M1 receptor agonists for the treatment of pain claimed by AstraZeneca
Read More
